Lung Institute | Buffalo New York

COPD Treatment Near Buffalo, NY

Chronic obstructive pulmonary disease, or COPD, is a progressive form of lung disease that ranges from mild to severe. It is the restriction of airflow into and out the lungs that makes breathing difficult. COPD refers to a group of lung conditions including emphysema and chronic bronchitis.

Many patients with COPD have trouble walking short distances and are prone to ongoing illnesses and pneumonia. Oxygen support is often required 24 hours a day to allow normal breathing. There is no cure for COPD, but treatment options are now available relatively nearby, in Pittsburgh, PA, to prevent more damage and hopefully improve the quality of life.

What Causes COPD?

The primary cause of COPD is tobacco smoke. Tobacco smoke destroys tissue and causes inflammation of the lungs. Inhaled tobacco toxins saturate pulmonary passageways and air sacs (alveoli), destroying structure and elasticity. Only some of the toxins leave the body when we exhale. Unfortunately, this type of lung damage is irreversible.

Consistent inhalation of pollutants can cause lung inflammation, leading to emphysema. The most common places people consume such pollutants is are in urban environments and near industries using chemicals or burning fossil fuels extensively.

On rare occasions, COPD can be caused by a genetic disorder that decreases the production of specific protein. This disorder is known as Alpha-1-antitrypsin. An alpha-1-antitrypsin deficiency may cause emphysema to develop in people who have never smoked cigarettes. Alpha-1-antitrypsin is a substance in the lungs that fights the enzyme trypsin (or protease). Trypsin is an enzyme released by immune cells in both the digestive tract and in the lungs, which fights bacteria or digests food. In people who are alpha-1-antitrypsin deficient, the lungs cannot fight the destructive nature of the trypsin. Therefore, the lung tissue is progressively weakened and destroyed, similar to what is found in a person who has smoked cigarettes.

Treating COPD

Stem cells are the body’s natural healing system. The Lung Institute state-of-the-art clinics harvest stem cells from a patient’s own blood or bone marrow and reintroduce them into the body, directing their healing ability toward lung tissue. This high dose of stem cells promote healing and helps patients breathe more easily.

The Lung Institute uses autologous stem cells, derived from the patient’s own body for the  bone marrow and the venous (blood-derived) stem cell procedures. Stem cells are extracted, isolated and immediately introduced back into the body where they replicate into healthy cells specialized to promote healing. All our stem cell procedures have shown anti-inflammatory properties beneficial to patients with lung disease.

The city of Pittsburgh leads lung disease research with programs like those at the Simmons Center for Interstitial Lung Disease at the University of Pittsburgh. The Pittsburgh Lung Institute clinic treats interstitial lung disease and other serious lung disorders including COPD, emphysema, chronic bronchitis, pulmonary fibrosis and black lung.

Lung disease is the third leading cause of death in the United States, and most traditional treatment options only treat the symptoms rather than the disease itself. Most who have been diagnosed with lung disease are prescribed a bronchodilator and daily medication to clear the respiratory path and reduce coughing. The advent of stem cell therapy is a game-changer for those with lung disease.

To date the Lung Institute has treated over 1,000 patients with stem cell therapy, and is excited to increase the number of improved lives with the addition of the Pittsburgh Clinic. Dr. Jack Coleman, Jr, MD, is the Medical Director for the Lung Institute in Pittsburgh. He earned his medical degree from the University of Cincinnati as well as completed his internship and general surgery residency at the institution. Dr. Coleman is a board certified in physician and ensures that all treatments and staff will follow strict standards with the highest excellence in personalized patient care.

About the Lung Institute

At the Lung Institute, we help those with lung disease breathe easier through innovative regenerative medicine solutions. We understand the challenges that lung disease sufferers face when it comes to finding the best treatment option in order to obtain a better quality of life. With this in mind, we are committed to providing our patients with the best and most effective treatment options to bring their lives back within reach. For more information, visit our website at LungInstitute.com, like us on Facebook, Follow us on Twitter or call us today at (800) 729-3065.

* All treatments performed at Lung Institute utilize autologous stem cells, meaning those derived from a patient's own body. No fetal or embryonic stem cells are utilized in Lung Institute's procedures. Lung Institute aims to improve patients' quality of life and help them breathe easier through the use of autologous stem cell therapy. To learn more about how stem cells work for lung disease, click here.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

Under current FDA guidelines and regulations 1271.10 and 1271.15, the Lung Institute complies with all necessary requirements for operation. Any individual who accesses Lung Institute's website for information is encouraged to speak with his or her primary physician for treatment suggestions and conclusive evidence. All information on this site should be used for educational and informational use only.